Secondary measles vaccine failure in healthcare workers exposed to infected patients

L K Ammari1, L M Bell, R L Hodinka

  • 1Department of Pediatrics, Children's Hospital of Philadelphia, PA 19104.

Abstract

Insights

Four vaccinated healthcare workers developed measles despite having pre-existing measles antibodies. This study highlights potential gaps in immunity detection and emphasizes the need for precautions in healthcare settings.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Measles remains a concern in healthcare settings, even with vaccination programs.
  • Assessing protective immunity through antibody levels can be complex.
  • Healthcare workers (HCWs) are at risk of exposure and transmission.

Purpose of the Study:

  • To describe cases of measles in HCWs with pre-existing measles antibodies.
  • To evaluate the effectiveness of current immunity assessment methods in HCWs.
  • To inform infection control practices for measles in hospitals.

Main Methods:

  • Screening of hospital employees for measles antibody levels using enzyme immunoassay (EIA).
  • Review of clinical course and laboratory data for HCWs who developed measles.
  • Inclusion of HCWs from various patient care roles at an academic tertiary care children's hospital.

Main Results:

  • Four vaccinated HCWs developed measles despite positive pre-illness measles antibody levels.
  • All affected HCWs showed a significant rise in measles-specific IgG post-infection.
  • Three of the four HCWs had received at least two measles vaccinations.

Conclusions:

  • Existing measles antibody levels may not always indicate adequate protective immunity in HCWs.
  • Respiratory precautions are recommended for all HCWs caring for measles patients.
  • Further research is needed to refine methods for assessing protective measles immunity in healthcare populations.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.